Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways

Abdelhabib Semlali(Université Laval), Mahmoud Rouabhia(Université Laval)
Frontiers in Oncology
September 15, 2022
Cited by 15


Related Papers